TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
CADL

Candel Therapeutics Inc

Healthcare · Biotechnology

11.00$ -4.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Candel Therapeutics Inc (CADL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 208 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CADL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
50 42 31 26 22 107 96 106 94 125 202 208
45 37 27 23 18 104 93 104 90 120 198 204
43 35 26 21 17 103 92 101 87 120 195 202
43 35 26 21 17 103 92 101 87 120 195 202
27 29 25 36 37 41 21 16 13 73 64 82
10 14 14 14 15 38 20 15 11 9.0 7.1 13
6.6 9.4 10 11 11 10 9.8 7.3 4.7 0.4 0.5 0.5
0.3 0.4 0.5 0.4 0.3 0.2 0.8 2.0 1.1 1.1 3.0 5.2
15 12 10.0 7.5 5.1 2.6 0.9 0.9 1.0 47 47 48
23 13 6.0 -10.0 -15 66 75 90 80 52 138 126
-126 -137 -145 -167 -178 -192 -185 -190 -201 -230 -239 -278
29 29 29 30 32 36 32 51 55 55 62 74

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?